IT1399791B1 - Composizioni farmaceutiche per il trattamento della poliposi nasale - Google Patents

Composizioni farmaceutiche per il trattamento della poliposi nasale

Info

Publication number
IT1399791B1
IT1399791B1 ITRM2009A000180A ITRM20090180A IT1399791B1 IT 1399791 B1 IT1399791 B1 IT 1399791B1 IT RM2009A000180 A ITRM2009A000180 A IT RM2009A000180A IT RM20090180 A ITRM20090180 A IT RM20090180A IT 1399791 B1 IT1399791 B1 IT 1399791B1
Authority
IT
Italy
Prior art keywords
treatment
pharmaceutical compositions
nasal polyposis
polyposis
nasal
Prior art date
Application number
ITRM2009A000180A
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITRM2009A000180A priority Critical patent/IT1399791B1/it
Application filed by Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L filed Critical Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L
Priority to DK10717816.2T priority patent/DK2421520T3/da
Priority to RS20130139A priority patent/RS52718B/en
Priority to PT107178162T priority patent/PT2421520E/pt
Priority to PCT/IB2010/051703 priority patent/WO2010122482A1/en
Priority to ES10717816T priority patent/ES2402601T3/es
Priority to PL10717816T priority patent/PL2421520T3/pl
Priority to EP10717816A priority patent/EP2421520B1/en
Publication of ITRM20090180A1 publication Critical patent/ITRM20090180A1/it
Priority to IL215854A priority patent/IL215854A/en
Priority to HK12106495.3A priority patent/HK1165724A1/xx
Application granted granted Critical
Publication of IT1399791B1 publication Critical patent/IT1399791B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ITRM2009A000180A 2009-04-20 2009-04-20 Composizioni farmaceutiche per il trattamento della poliposi nasale IT1399791B1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITRM2009A000180A IT1399791B1 (it) 2009-04-20 2009-04-20 Composizioni farmaceutiche per il trattamento della poliposi nasale
RS20130139A RS52718B (en) 2009-04-20 2010-04-19 ALBUMIN AND / OR MANITOL FOR THE TREATMENT OF NASAL POLYPOSIS
PT107178162T PT2421520E (pt) 2009-04-20 2010-04-19 Albumina e/ou manitol para o tratamento de polipose nasal
PCT/IB2010/051703 WO2010122482A1 (en) 2009-04-20 2010-04-19 Pharmaceutical compositions for the treatment of nasal polyposis
DK10717816.2T DK2421520T3 (da) 2009-04-20 2010-04-19 Albumin og/eller mannitol til behandling af nasal polypose
ES10717816T ES2402601T3 (es) 2009-04-20 2010-04-19 Albúmina y/o manitol para el tratamiento de la poliposis nasal
PL10717816T PL2421520T3 (pl) 2009-04-20 2010-04-19 ALBUMINA i/lub MANNITOL DO LECZENIA POLIPÓW NOSA
EP10717816A EP2421520B1 (en) 2009-04-20 2010-04-19 Albumin and/or mannitol for the treatment of nasal polyposis
IL215854A IL215854A (en) 2009-04-20 2011-10-23 Pharmaceutical compounds for the treatment of nasal polyposis
HK12106495.3A HK1165724A1 (en) 2009-04-20 2012-07-04 Albumin and/or mannitol for the treatment of nasal polyposis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2009A000180A IT1399791B1 (it) 2009-04-20 2009-04-20 Composizioni farmaceutiche per il trattamento della poliposi nasale

Publications (2)

Publication Number Publication Date
ITRM20090180A1 ITRM20090180A1 (it) 2010-10-21
IT1399791B1 true IT1399791B1 (it) 2013-05-03

Family

ID=41203922

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2009A000180A IT1399791B1 (it) 2009-04-20 2009-04-20 Composizioni farmaceutiche per il trattamento della poliposi nasale

Country Status (10)

Country Link
EP (1) EP2421520B1 (it)
DK (1) DK2421520T3 (it)
ES (1) ES2402601T3 (it)
HK (1) HK1165724A1 (it)
IL (1) IL215854A (it)
IT (1) IT1399791B1 (it)
PL (1) PL2421520T3 (it)
PT (1) PT2421520E (it)
RS (1) RS52718B (it)
WO (1) WO2010122482A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030485B1 (ru) 2013-04-29 2018-08-31 Харша Чигурупати Спиртные напитки с пониженной гепатотоксичностью

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058612C (zh) * 1994-06-22 2000-11-22 刘廷栋 一种治疗鼻息肉的药膏
WO2004006959A1 (en) * 2002-07-16 2004-01-22 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
US8535707B2 (en) * 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US20100233272A1 (en) * 2007-11-15 2010-09-16 Leah Elizabeth Appel Dosage forms comprising celecoxib providing both rapid and sustained pain relief

Also Published As

Publication number Publication date
ES2402601T3 (es) 2013-05-07
PL2421520T3 (pl) 2013-06-28
WO2010122482A1 (en) 2010-10-28
EP2421520B1 (en) 2013-01-16
DK2421520T3 (da) 2013-04-29
EP2421520A1 (en) 2012-02-29
IL215854A0 (en) 2012-01-31
PT2421520E (pt) 2013-04-15
HK1165724A1 (en) 2012-10-12
ITRM20090180A1 (it) 2010-10-21
IL215854A (en) 2014-11-30
RS52718B (en) 2013-08-30

Similar Documents

Publication Publication Date Title
CY2020008I1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
SMT201600055B (it) Composizione farmaceutica per il trattamento o la prevenzione del glaucoma
SMT201700095B (is) Composizioni farmaceutiche per inalazione
PT2482812T (pt) Composições farmacêuticas compreendendo bi-1356 e metformina
IL219073A (en) A drug combination for cancer treatment
DK2403569T3 (da) Lægemiddelafgivelsesanordning med tilbagetrækkelig nål
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1011587A2 (pt) compostos e composições terapèuticas
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
BRPI1004940A2 (pt) composição farmacêutica
SMT201400069B (it) Formulazione farmaceutica
DK2506712T3 (da) Morfinanderivater til behandling af lægemiddeloverdosering
BRPI1012539A2 (pt) composições farmacêuticas
SMT201400057B (it) Composizione per il trattamento della fibrosi cistica
BRPI1015939A2 (pt) composição farmacêutica
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI1014688A2 (pt) aplicações terapêuticas de derivados de quinazolinadiona
IT1394400B1 (it) Composizioni farmaceutiche
DK2482881T3 (da) Mekanisme til indretning til indlevering af lægemiddel
BRPI0922653A2 (pt) preparação farmacêutica
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
EE201300004A (et) Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks
BR112012003149A2 (pt) composição farmacêutica
BR112012001340A2 (pt) composições farmacêuticas